Nuo Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Nuo Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q3 2024.
  • Nuo Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $188K, a 35.8% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $188K -$105K -35.8% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $204K -$111K -35.2% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $220K -$117K -34.7% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $269K -$89.9K -25% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $293K -$88K -23.1% Sep 30, 2023 10-Q 2023-11-20
Q2 2023 $315K -$86.4K -21.5% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $338K +$254K +302% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $359K +$359K Dec 31, 2022 10-K 2024-04-19
Q3 2022 $381K Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $402K Jun 30, 2022 10-Q/A 2022-08-10
Q1 2022 $84K Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $0 Dec 31, 2021 10-K 2023-04-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.